Answers are grounded in this paper and cite their sources.
Background: Adenomyosis often coexists with uterine leiomyomas and affects uterus-sparing treatment, but it is difficult to see on transabdominal ultrasound (US). We assessed how often MRI showed adenomyosis in women with a leiomyoma as the main lesion, and whether the preceding US reported it. Methods: We reviewed the reports of 91 consecutive women who underwent transabdominal US followed by 1.5-T pelvic MRI for a gynaecological indication in Jazan, Saudi Arabia (May 2023–July 2025). Women whose main MRI lesion was a leiomyoma formed the study group. We assessed agreement between US and MRI using Cohen’s kappa, PABAK, and the exact McNemar test, and compared groups using Fisher’s exact and Mann–Whitney U tests. Results: Fifty-one women (mean age 44.1 ± 9.5 years) had a leiomyoma as the main lesion, and 13 of them (25.5%; 95% CI 14.3–39.6) also had adenomyosis on MRI. Age was similar (43.2 vs 44.4 years; p = 0.72), but women with coexisting adenomyosis were more often referred for menstrual symptoms (38.5% vs 10.5%; p = 0.036). In these 13 women, transabdominal US reported a leiomyoma in 11 and an ovarian or adnexal cyst in 2, and it reported adenomyosis in none (0/13; 95% CI 0–24.7; κ = 0.00; PABAK = 0.49; McNemar p < 0.001). Conclusion: About one in four women with a leiomyoma on MRI also had adenomyosis, which the preceding transabdominal US did not report. MRI should be considered before uterus-sparing treatment of presumed leiomyomas, particularly in women with heavy bleeding or dysmenorrhoea.
No takes yet. Share an insight, caveat, or question.
Saidahmed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: